Comment by josho
3 years ago
Pharma would market a phase 2 trial drug as a “potential revolution in treatment. Only a select few can receive this treatment and as a result it costs 10x more than existing drugs. Ps. We don’t guarantee results.”
Is that really the outcome you want?
Fewer people dying and more people overpaying for ineffective treatment is potentially a good tradeoff. As a society we already funnel massive amounts of cash to new medical treatments, we just do it in a really inefficient way.
What I want is fewer people to die while waiting for the FDA to take years to approve already existing drugs.
You seem to care more about marketing than people's lives. We all have different priorities.
(Not the OP) In a macro sense, I'd agree with you; no stranger to having to weigh the risks/rewards of experimental drugs.
But at the same time, I do get why extensive approval is needed - deaths can and often do occur from allergic reactions and/or side effects to medicines, and the idea is to hopefully lower the ratio of that happening. At some point more people "will" die from allergic reactions/side effects than the time it takes to get approval.
What people usually miss is the cost in lives of delays in approving or developing cures:
https://marginalrevolution.com/marginalrevolution/2021/01/th...